Overview
David Segal practices practicing medicine in Potchefstroom, South Africa.
His clinical expertise encompasses Type 1 Diabetes (T1D), Fanconi Anemia, and Congenital Aplastic Anemia.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about David G. Segal
Is David G. Segal a top-rated expert for Type 1 Diabetes (T1D)?
MediFind is an objective health platform that identifies experts based on real-world data. David G. Segal is classified as an Experienced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does David G. Segal participate in research or clinical trials?
Yes. David G. Segal has published 16 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of David G. Segal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Congenital Aplastic AnemiaMr. Segal isExperienced. Learn about Congenital Aplastic Anemia.
- Fanconi AnemiaMr. Segal isExperienced. Learn about Fanconi Anemia.
- Type 1 Diabetes (T1D)Mr. Segal isExperienced. Learn about Type 1 Diabetes (T1D).